Trial site
Helios Klinikum Erfurt
- 13running trials
- 9closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Stroke5 trials
- Brain aneurysm3 trials
- Heart failure3 trials
- Melanoma3 trials
- Atrial fibrillation2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Coronary artery disease1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Glioblastoma1 trial
- and 2 more
- Phase
- Phase 35 trials
- Phase 22 trials
- Status
- Recruiting9 trials
- Completed8 trials
- Active, not recruiting3 trials
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern2 trials
- Phenox GmbH2 trials
- Actelion1 trial
- Biotronik SE & Co. KG1 trial
- Deutsches Herzzentrum Muenchen1 trial
- and 15 more
Running trials
Recruiting
Recruiting
Recruiting
Early Catheter-directed Treatment of High Risk Pulmonary Embolism
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart Failure (HF) Outcomes
Recruiting
Recruiting
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Recruiting
Recruiting
Recruiting
Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation2 recruiting
- Stroke2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Brain aneurysm1 recruiting
- Childhood cancers1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Glioblastoma1 recruiting
- Heart failure1 recruiting
- Lung cancer1 recruiting
Closed trials
Completed
Completed
ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2
Completed
Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation
Completed
BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients
Completed
Completed
Completed
Recruiting
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026